Please provide your email address to receive an email when new articles are posted on . Healio has compiled the most-read news in pulmonology posted in May. Highlights include an oral drug combination ...

Combined treatments for both aspects of obstructive sleep apnea (OSA)—a compromised airway anatomy and unstable ...

For the first time, researchers have shown that tackling obstructive sleep apnea’s two root causes at once, using both oxygen ...

The American Academy of Sleep Medicine has indicated that an estimated 26 percent of adults between the ages of 30 and 70 years have sleep apnea. (Photo: Getty) You could say that it’s difficult to ...

The FDA has expanded the approval of Eli Lillys obesity medication Zepbound to include treating moderate to severe obstructive sleep apnea for people with obesity -- the first medication approved for ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. In COPD and obstructive sleep apnea, nocturnal hypoxemia ...

The Food and Drug Administration (FDA) gave the green light to the the first-ever medication for obstructive sleep apnea (OSA). The newly approved drug, Zepbound (tirzepatide), targets adults with ...